Clover Health Investments Corp (NAS:CLOV)
$ 3.26 -0.05 (-1.51%) Market Cap: 1.63 Bil Enterprise Value: 1.33 Bil PE Ratio: 0 PB Ratio: 4.77 GF Score: 35/100

Clover Health Investments Corp at Barclays Global Healthcare Conference Transcript

Mar 15, 2022 / 03:15PM GMT
Release Date Price: $2.88 (+8.27%)
Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

Okay. We're going to get started on our next session here. I'm Steven Valiquette, the Health Care Services Analyst here at Barclays. Next company up is Clover Health.

With us from the company, we have Vivek Garipalli, from -- he's a CEO. And I guess it's going to be a fireside chat, right? I'm going to turn it to you for any remarks. We're just going to dive right in on the questions. Is that okay, right? That makes it easy then. Okay. Great.

Questions & Answers

Steven James Valiquette
Barclays Bank PLC, Research Division - Research Analyst

All right. So yes, I think just kicking things off, I think at a high level, I think investors understand that you're focused on the Medicare Advantage market, and you have some payer answer provider assets. Maybe it wouldn't hurt just maybe just give a quick overview of what makes the company a little bit different from some of the other offerings that are out there when people think about the Medicare Advantage marketplace

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot